Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modeling HIV infection, treatment, rebound, and intervention in human immune organoids.

bioRxiv : the preprint server for biology·2026

Same author

Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in "Kick-and-Kill" HIV Cure Approaches.

bioRxiv : the preprint server for biology·2026

Same author

NK Cells Engineered with a Chimeric Antigen Receptor Delay HIV Rebound and Reshape HIV Reservoir Composition.

bioRxiv : the preprint server for biology·2026

Same author

Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.

Nature communications·2025

Same author

Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.

Nature communications·2025

Same author

Rapamycin enhances CAR-T control of HIV replication and reservoir elimination in vivo.

The Journal of clinical investigation·2025

Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026

Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026

Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026

Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026

Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026

Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 25, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Neutralizing the HIV reservoir.

Matthew D Marsden¹, Jerome A Zack²

¹Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA AIDS Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.

|August 30, 2014

Summary

This summary is machine-generated.

Broadly neutralizing antibodies combined with HIV latency activators reduced persistent HIV reservoirs in a humanized mouse model. This approach shows promise for purging latent HIV, a critical step toward an HIV cure.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Related Experiment Videos

Last Updated: Apr 25, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Area of Science:

Immunology
Virology
Infectious Diseases

Background:

Persistent HIV reservoirs are a major barrier to curing HIV infection.
Current antiretroviral therapy controls viral replication but does not eliminate latent HIV.
Novel strategies are needed to target and purge these latent reservoirs.

Purpose of the Study:

To investigate the efficacy of broadly neutralizing antibodies (bNAbs) in combination with HIV latency activators.
To determine if this combination therapy can reduce persistent HIV reservoirs in vivo.
To assess the impact on viral rebound after treatment cessation.

Main Methods:

Utilized a humanized mouse model engrafted with human immune cells and infected with HIV.
Administered a combination of bNAbs and latency-activating compounds.
Monitored plasma HIV RNA levels and measured reservoir size post-treatment.

Main Results:

The combination therapy significantly reduced persistent HIV reservoirs.
Reduced viral loads were observed, indicated by delayed or absent plasma virus rebound.
This demonstrates a potential strategy for HIV reservoir purging.

Conclusions:

Broadly neutralizing antibodies combined with latency activators can effectively reduce latent HIV reservoirs.
This therapeutic approach offers a promising strategy for HIV cure research.
Further investigation in clinical settings is warranted to translate these findings.